President Donald Trump could sign a sweeping executive order banning gain-of-function research — research that makes viruses ...

Parker previously served as the head of the National Science Advisory Board for Biosecurity (NSABB ... All republished articles must include our logo, our reporter’s byline and their DCNF ...

Hammerspace, the high-performance Data Platform for AI, today announced that several strategic venture investors, who were early backers of transformative companies like NVIDIA, Meta, Palantir, SpaceX ...

The Advance propaganda machine is aimed at ordinary Australians but backed by some of our wealthiest – and has links to a right-wing US foundation.

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

Scala is among the top 20 programming languages in the world and is used among hundreds of leading technology companies for ...

Scientists, with expertise in fields that include mental health, cancer and infectious disease, typically serve five-year ...

Langer, ScD will join the company’s Scientific Advisory Board (SAB) upon the successful completion of Decoy’s merger with Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX). As announced on January ...

Tempus AI has launched an advisory board of oncology experts to provide guidance and strategic advice to the Chicago-based company on research, product development and clinical use of it's AI-enabled ...

SAN DIEGO, April 16, 2025 /PRNewswire/ -- NEUVOGEN, Inc., a San Diego based biotechnology company with a next-generation cancer vaccine platform, announced today the appointments of James P.